Insider Buying: Bonk (NASDAQ:BNKK) Director Purchases $17,138.73 in Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy bought 11,659 shares of the company’s stock in a transaction that occurred on Thursday, July 2nd. The stock was acquired at an average cost of $1.47 per share, for a total transaction of $17,138.73. Following the acquisition, the director directly owned 85,000 shares of the company’s stock, valued at $124,950. The trade was a 15.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Mitchell Austin Rudy also recently made the following trade(s):

• On Monday, June 22nd, Mitchell Austin Rudy purchased 7,500 shares of Bonk stock. The shares were acquired at an average cost of $1.56 per share, with a total value of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The shares were acquired at an average cost of $1.32 per share, with a total value of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy acquired 12,000 shares of Bonk stock. The stock was acquired at an average price of $1.37 per share, for a total transaction of $16,440.00.
• On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The shares were acquired at an average cost of $2.82 per share, for a total transaction of $87,575.10.

Bonk Stock Down 6.1%

Bonk stock traded down $0.09 during mid-day trading on Tuesday, hitting $1.39. The company had a trading volume of 152,991 shares, compared to its average volume of 841,628. Bonk, Inc. has a 1 year low of $1.25 and a 1 year high of $46.90. The business has a fifty day moving average of $1.87 and a 200 day moving average of $2.80. The stock has a market cap of $11.12 million, a price-to-earnings ratio of -0.30 and a beta of 1.89.

Bonk (NASDAQ:BNKK) last issued its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The company had revenue of $0.79 million during the quarter.

Hedge Funds Weigh In On Bonk

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC acquired a new stake in Bonk during the 4th quarter worth approximately $128,000. Jane Street Group LLC purchased a new stake in shares of Bonk during the fourth quarter worth approximately $96,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk during the fourth quarter worth $37,000. Finally, State Street Corp acquired a new stake in shares of Bonk during the fourth quarter worth $33,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a research note on Saturday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Bonk has an average rating of “Sell”.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.